US2012053563A1PendingUtilityA1
Non-sedating antihistamine injection formulations and methods of use thereof
Est. expiryJul 3, 2029(~3 yrs left)· nominal 20-yr term from priority
Inventors:Jie Du
A61P 37/08A61K 31/341A61K 9/0019A61K 45/06A61K 31/495A61K 31/4164A61K 31/4545A61P 17/04A61K 31/573A61P 17/00A61K 31/137A61K 31/445A61P 11/00
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are automatic injectors suitable for administration of a non-sedating antihistamine, and methods of using the automatic injectors. A specific non-sedating antihistamine is cetirizine. The automatic injectors are useful in treating acute urticaria or angioedema associated with an acute allergic reaction including anaphylaxis.
Claims
exact text as granted — not AI-modified1 . A method of treating acute urticaria or angioedema associated with an acute allergic reaction including anaphylaxis in an individual in need thereof, comprising
self-administering from an automatic injector a pre-measured dose of a non-sedating antihistamine composition subcutaneously or intramuscularly, wherein the non-sedating antihistamine composition comprises a non-sedating antihistamine and a pH adjusting agent and has a pH of 3 to 9, wherein the non-sedating antihistamine comprises cetirizine or a salt thereof, wherein the automatic injector comprises a housing comprising a chamber for the non-sedating antihistamine composition and a dispensing assembly in communication with the chamber.
2 . The method of claim 1 , wherein the non-sedating antihistamine composition further comprises ranitidine, cimetidine, epinephrine, methylprednisolone, prednisolone, or a combination thereof.
3 . The method of claim 1 , further comprising self-administering from a second automatic injector an epinephrine composition, wherein the second automatic injector comprises a second housing comprising a second chamber for the epinephrine composition and a second dispensing assembly in communication with the second chamber.
4 . The method of claim 1 , wherein treating is in an emergency situation.
5 . The method of claim 1 , wherein self-administering the non-sedating antihistamine from the automatic injector is non-cardiotoxic and non-sedating.
6 . An automatic injector for self-administration of a pre-measured dose of a non-sedating antihistamine composition subcutaneously or intramuscularly, comprising
a housing comprising a chamber for the non-sedating antihistamine composition and a dispensing assembly in communication with the chamber, wherein the non-sedating antihistamine composition comprises a non-sedating antihistamine and a pH adjusting agent and has a pH of 3 to 9, wherein the non-sedating antihistamine comprises cetirizine or a salt thereof.
7 . The automatic injector of claim 6 , wherein the non-sedating antihistamine composition further comprises ranitidine, cimetidine, epinephrine, methylprednisolone, prednisolone, or a combination thereof.
8 . A kit comprising the automatic injector comprising a non-sedating antihistamine composition of claim 6 , and a second automatic injector comprising a second housing comprising a second chamber for an epinephrine composition and a second dispensing assembly in communication with the second chamber.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.